Cargando…

Prognostic Nomogram for Overall Survival of Patients Aged 50 Years or Older with Cervical Cancer

OBJECTIVE: The prognostic factors of cervical cancer in elderly patients have not been researched systematically. We aimed to investigate the clinicopathological characteristics of patients with cervical cancer aged ≥50 years and establish a nomogram for evaluating their prognoses for overall surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Jing, He, Yue, Wang, Ming, Wu, Yumei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579836/
https://www.ncbi.nlm.nih.gov/pubmed/34785932
http://dx.doi.org/10.2147/IJGM.S335409
Descripción
Sumario:OBJECTIVE: The prognostic factors of cervical cancer in elderly patients have not been researched systematically. We aimed to investigate the clinicopathological characteristics of patients with cervical cancer aged ≥50 years and establish a nomogram for evaluating their prognoses for overall survival. METHODS: From the Surveillance, Epidemiology, and End Results database, we obtained data of 8538 patients with pathology-confirmed cervical cancer between 2004 and 2015. Patients were divided into training (n = 5941) and validation (n = 2597) cohorts. A nomogram was constructed to evaluate the prognostic prediction value for disease progression. The concordance index, receiver operating characteristic curve, and calibration chart were used to evaluate the model’s prediction accuracy and discriminative ability. Survival condition was analyzed using the Kaplan–Meier method. RESULTS: In the training cohort, age at diagnosis, race, histology, grade, stage, tumor size, number of examined lymph nodes, and treatment significantly correlated with outcome and were used to develop the nomogram. The calibration curve for survival probability showed an excellent agreement between the nomogram-predicted and actual survival in the training cohort. CONCLUSION: Our nomogram has less bias and gives better accuracy than the International Federation of Gynecology and Obstetrics staging system and can help set up a more individualized feasible follow-up plan.